US 10307410
Mcl-1 modulating compounds for cancer treatment
granted A61KA61K31/444A61K31/506
Quick answer
US patent 10307410 (Mcl-1 modulating compounds for cancer treatment) held by INSTITUT DE CANCEROLOGIE DE L'OUEST RENE GAUDUCHEAU expires Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- INSTITUT DE CANCEROLOGIE DE L'OUEST RENE GAUDUCHEAU
- Grant date
- Tue Jun 04 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 30 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/444, A61K31/506, A61P, A61P35/00